Skip to main content
. 2011 Oct 18;119(1):296–307. doi: 10.1182/blood-2011-06-364265

Table 1.

Patient characteristics

Variable SD
URD
No. assessable No. % No. assessable No. %
Recipient age, y 3191 2370
    Median 42.7 44.2
    Range 20-74 20-74
    20-29 617 19 447 19
    30-39 741 23 493 21
    40-49 872 27 644 27
    50-59 734 23 587 25
    ≥ 60 227 7 199 8
Sex 3191 2370
    Male 1796 56 1309 55
    Female 1395 44 1061 45
Donor age, y 3191 2370
    Median 41.6 35.4
    Range < 1-75 18.6-60.6
    < 10 15 < 1
    10-19 163 5 24 1
    20-29 476 15 677 29
    30-39 773 24 888 37
    40-49 844 26 612 26
    ≥ 50 872 27 169 7
    Missing 48 2
Donor–recipient sex match
    Male→male 1034 32 854 36
    Male→female 709 22 638 27
    Female→male 756 24 455 19
    Female→female 683 21 423 18
    Unknown 9 < 1
KPS 3191 2370
    < 80 260 8 216 9
    80-100 2824 88 1906 80
    Unknown 107 3 248 10
Disease type 3191 2370
    AML 1377 43 1044 44
    ALL 516 16 446 19
    CML 831 26 463 20
    MDS 467 15 417 18
Disease status at transplant 3191 2370
    Early 1761 55 907 38
    Intermediate 528 17 568 24
    Advanced 681 21 707 30
    Other 221 7 188 8
Recipient race 3191 2370
    White 2239 70 2063 87
    Other 952 30 307 13
Donor race 3191 2370
    White 2239 70 1941 82
    Other 95 30 429 18
Recipient–donor CMV status 3191 2370
    R−/D− 624 20 738 31
    R+/D− 461 14 775 33
    R−/D+ 301 9 289 12
    R+/D+ 1656 52 552 22
    Unknown 149 5 46 2
Donor pregnancy 3191 2370
    Male 1743 55 1492 62
    Female, no pregnancy 276 9 343 14
    Female, > 1 pregnancy 730 23 500 21
    Unknown 442 14 35 1

KPS indicates Karnofsky performance score; MDS, myelodysplastic syndrome; R, recipient; and D, donor.